Journal article

A Novel Small Molecule GDNF Receptor RET Agonist, BT13, Promotes Neurite Growth from Sensory Neurons in Vitro and Attenuates Experimental Neuropathy in the Rat

Yulia A Sidorova, Maxim M Bespalov, Agnes W Wong, Oleg Kambur, Viljami Jokinen, Tuomas O Lilius, Ilida Suleymanova, Gunnar Karelson, Pekka V Rauhala, Mati Karelson, Peregrine B Osborne, Janet R Keast, Eija A Kalso, Mart Saarma

Frontiers in Pharmacology | FRONTIERS MEDIA SA | Published : 2017

Grants

Awarded by European Union Seventh Framework Programme (FP7)


Awarded by FP7-PEOPLE-IAPP


Awarded by Centre of Excellence in Molecular Cell Engineering, Estonia


Awarded by Estonian Research Council


Awarded by NHMRC of Australia


Funding Acknowledgements

The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement No 602919 (to EK); FP7-PEOPLE-2013-IAPP under grant agreement No. 612275, CIMO, Genecode Ltd., Chemedest Ltd., Lundbeck Foundation, Sigrid Juselius Foundation (to MS); Centre of Excellence in Molecular Cell Engineering, Estonia, 2014-2020.4.01.15-013, grant PUT582 from the Estonian Research Council (to MK); and NHMRC of Australia project 1024552 (to JK).